MedPath

Phase II study of TS-1 + CPT-11 for squamous cell lung cancer previously treated with platinum

Not Applicable
Conditions
on-small cell lung cancer (squamous cell carcinoma)
Registration Number
JPRN-UMIN000006065
Lead Sponsor
orth Japan Lung Cancer Group
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

1. With obvious interstitial pneumonitis 2. With active other malignancies 3. With massive effusion required tube drainage 4. With severe comorbidities 5. With symptomatic brain metastasis 6. With other conditions that is considered inappropriate for the study by an attending physician

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Response rate
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath